Other
SF-12
SF-12 is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting1
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
active_not_recruiting133%
recruiting133%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_1
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575
recruiting
Digital Addiction Among University Students
NCT06584253
completednot_applicable
Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19
NCT04834739
Clinical Trials (3)
Showing 3 of 3 trials
NCT04046575Phase 1
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT06584253
Digital Addiction Among University Students
NCT04834739Not Applicable
Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3